Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial

被引：0
作者：
Farastuk Bozorgmehr
Petros Christopoulos
Inn Chung
Jelena Cvetkovic
Manuel Feißt
Johannes Krisam
Marc A. Schneider
Claus Peter Heußel
Michael Kreuter
Daniel W. Müller
Michael Thomas
Stefan Rieken
机构：
[1] Thoraxklinik at University Hospital of Heidelberg,Department of Thoracic Oncology
[2] Member of the German Center for Lung Research DZL,Translational Lung Research Center Heidelberg TLRCH
[3] Institute of Medical Biometry,University Hospital of Heidelberg
[4] Translational Research Unit (STF),Thoraxklinik at University Hospital of Heidelberg
[5] Diagnostic and Interventional Radiology with Nuclear Medicine,Thoraxklinik at University Hospital of Heidelberg
[6] Pneumology and Respiratory Care Medicine,Thoraxklinik at University Hospital of Heidelberg, Center for Interstitial and Rare Lung Diseases
[7] Institute of Clinical Cancer Research IKF GmbH at Northwest Hospital,Department of Radiation Oncology
[8] University Medical Center Göttingen,undefined
来源：
BMC Cancer | / 22卷
关键词：
Extensive disease small cell lung cancer; SCLC; Radioimmuntherapy; Thoracic radiotherapy; Atezolizumab; Anti-PD-L1 monoclonal antibody; First-line therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen
    Reck, M
    Groth, G
    Buchholz, E
    Goetz, E
    Gatzemeier, U
    Manegold, C
    LUNG CANCER, 2005, 48 (03) : 409 - 413
  • [22] A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER
    Ikeda, Takaya
    Taniguchi, Hirokazu
    Soda, Hiroshi
    Fukuda, Minoru
    Kinoshita, Akihito
    Fukuda, Masaaki
    Soejima, Yoshifumi
    Ogawara, Daiki
    Nakamura, Yoichi
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1157 - S1157
  • [23] A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer
    Pallis, Athanasios G.
    Agelidou, Athina
    Agelaki, Sofia
    Varthalitis, Ioannis
    Pavlakou, Georgia
    Gerogianni, Aleka
    Papakotoulas, Pavlos
    Rapti, Ageliki
    Chandrinos, Vassilis
    Christophyllakis, Charalampos
    Georgoulias, Vassilis
    LUNG CANCER, 2009, 65 (02) : 187 - 191
  • [24] A PHASE II STUDY OF AMRUBICIN AND TOPOTECAN COMBINATION THERAPY IN PATIENTS WITH RELAPSED OR EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER: OKAYAMA LUNG CANCER STUDY GROUP TRIAL 0401
    Nogami, Naoyuki
    Kozuki, Toshiyuki
    Shinkai, Tetsu
    Katou, Yuka
    Hotta, Katsuyki
    Takigawa, Nagio
    Tabata, Masahiro
    Kiura, Katsuyuki
    Tanimoto, Mitsune
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S643 - S644
  • [25] Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase
    Qin, Tao
    Zhou, Ningning
    Zeng, Yin-duo
    Dinglin, Xiaoxiao
    Zhao, Yuanyuan
    Liu, Huai
    Chen, Likun
    ONCOTARGETS AND THERAPY, 2016, 9 : 1095 - 1103
  • [26] AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trial
    Zhao, Yuanyuan
    Chen, Gang
    Chen, Jianhua
    Zhuang, Li
    Du, Yingying
    Yu, Qitao
    Zhuang, Wu
    Zhao, Yanqiu
    Zhou, Ming
    Zhang, Weidong
    Zhang, Yu
    Wan, Yixin
    Li, Wenting
    Song, Weifeng
    Wang, Zhongmin Maxwell
    Li, Baiyong
    Xia, Michelle
    Yang, Yunpeng
    Fang, Wenfeng
    Huang, Yan
    Zhang, Li
    ECLINICALMEDICINE, 2023, 62
  • [27] Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer
    Haslett, K.
    Koh, P.
    Hudson, A.
    Ryder, W. D.
    Falk, S.
    Mullan, D.
    Taylor, B.
    Califano, R.
    Blackhall, F.
    Faivre-Finn, C.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 28 : 24 - 31
  • [28] A DPC Database Study on the Safety of Atezolizumab/Carboplatin/Etoposide in Extensive-Disease Small Cell Lung Cancer in Japanese Patients
    Tamiya, Motohiro
    Iwasawa, Shunichiro
    Sasaki, Yusuke
    Tajima, Kosei
    Chiba, Yasutaka
    ADVANCES IN THERAPY, 2024, 41 (09) : 3539 - 3556
  • [29] The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multicenter Prospective Cohort Study
    Choi, Myeong Geun
    Kim, Yeon Joo
    Lee, Jae Cheol
    Ji, Wonjun
    Oh, In-Jae
    Lee, Sung Yong
    Yoon, Seong Hoon
    Lee, Shin Yup
    Lee, Jeong Eun
    Kim, Eun Young
    Choi, Chang-Min
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 422 - 429
  • [30] Role of Consolidative Thoracic Radiotherapy for Extensive-stage Small Cell Lung Cancer: Trod Thoracic Oncology Study Group 08-006 Multi-institutional Study
    Yavas, Guler
    Kirakli, Esra Korkmaz
    Dagdelen, Meltem
    Topkan, Erkan
    Saynak, Mert
    Dincbas, Fazilet Oner
    OzdemIr, Yurday
    Yavas, Cagdas
    Birgi, Sumerya Duru
    Akyurek, Serap
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2022, 37 (01): : 9 - 15
12345